BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25861751)

  • 1. miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.
    Long QZ; Du YF; Liu XG; Li X; He DL
    Tumour Biol; 2015 Sep; 36(9):7017-26. PubMed ID: 25861751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
    Long QZ; Zhou M; Liu XG; Du YF; Fan JH; Li X; He DL
    Anticancer Drugs; 2013 Sep; 24(8):810-7. PubMed ID: 23744557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine.
    Meyer N; Duensing S; Anastassiou G; Brevis Nunez F; Grosse J; Ganser A; Atzpodien J
    Anticancer Res; 1999; 19(2C):1509-12. PubMed ID: 10365134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.
    Duensing S; Brevis Nunez F; Meyer N; Anastassiou G; Nasarek A; Grosse J; Buer J; Probst M; Ganser A; Alzpodien J
    Invasion Metastasis; 1996; 16(2):65-72. PubMed ID: 9030241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.
    Sun X; Lou L; Zhong K; Wan L
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1299-1305. PubMed ID: 28429654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
    Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
    Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
    Lu C; Shan Z; Li C; Yang L
    Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1.
    Li S; Yang J; Wang J; Gao W; Ding Y; Ding Y; Jia Z
    Cell Biosci; 2018; 8():9. PubMed ID: 29445446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil modulation of multidrug resistance in renal cell carcinoma.
    Yu DS; Sun GH; Ma CP; Chang SY
    J Formos Med Assoc; 2000 Apr; 99(4):311-6. PubMed ID: 10870315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
    Yu DS; Chang SY; Ma CP
    Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
    Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
    Huang M; Jin J; Sun H; Liu GT
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1015-26. PubMed ID: 18270702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1.
    Zhang Y; Qu X; Li C; Fan Y; Che X; Wang X; Cai Y; Hu X; Liu Y
    Tumour Biol; 2015 Apr; 36(4):2277-85. PubMed ID: 25407491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-340 regulates the growth and metabolism of renal cell carcinoma cells by targeting frizzled class receptor 3.
    Xiang M; Huang Y; Dai C; Zou G
    Arch Pharm Res; 2021 Feb; 44(2):219-229. PubMed ID: 33609235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
    Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
    Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.